(NASDAQ: TRIB) Trinity Biotech's forecast annual revenue growth rate of 17.89% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.73%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.87%.
Trinity Biotech's revenue in 2024 is $56,832,000.On average, 1 Wall Street analysts forecast TRIB's revenue for 2024 to be $10,271,788,760, with the lowest TRIB revenue forecast at $10,271,788,760, and the highest TRIB revenue forecast at $10,271,788,760.
In 2025, TRIB is forecast to generate $11,268,305,580 in revenue, with the lowest revenue forecast at $11,268,305,580 and the highest revenue forecast at $11,268,305,580.